Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) Stock
Stocks
RMDA
EGS381B1C015
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.980 EGP | -2.16% |
|
-0.60% | +49.55% |
| 05-19 | Egypt's Rameda Q1 standalone profit EGP 105.2 million | RE |
| 05-19 | Rameda FY dividend/share EGP 0.03 | RE |
| Market Cap | 9.96B 201M 176M 163M 150M 285M 19.22B 290M 1.95B 759M 9.41B 754M 737M 32.65B | P/E 2026 * |
18.1x | P/E 2027 * | 12.3x |
|---|---|---|---|---|---|
| Enterprise Value | 11.97B 241M 212M 195M 181M 342M 23.1B 349M 2.35B 912M 11.3B 906M 886M 39.24B | EV / Sales 2026 * |
2.5x | EV / Sales 2027 * | 2.07x |
| Free-Float |
39.85% | Yield 2026 * |
1.28% | Yield 2027 * | 3.1% |
| 1 day | -2.16% | ||
| 1 week | -0.60% | ||
| Current month | +0.61% | ||
| 1 month | -4.78% | ||
| 3 months | +12.67% | ||
| 6 months | +55.14% | ||
| Current year | +49.55% |
| 1 week | 4.91 |  | 5.15 |
| 1 month | 4.81 | | 5.29 |
| Current year | 3.06 | | 5.38 |
| 1 year | 3.02 | | 5.38 |
| 3 years | 0.99 | | 5.38 |
| 5 years | 0.8 | | 5.38 |
| 10 years | 0.8 | | 5.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
Amr Morsy
CEO | Chief Executive Officer | - | 2010-12-31 |
Aboamira Mohamed
DFI | Director of Finance/CFO | - | 2014-07-31 |
Mahmoud Fayek
DFI | Director of Finance/CFO | - | 2018-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 67 | 2018-12-31 | |
| Director/Board Member | - | 2010-12-31 | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.16% | -0.60% | +49.81% | +338.26% | 209M | |
| -1.60% | +2.02% | +56.34% | +168.94% | 1,102B | |
| -1.44% | +3.71% | +69.07% | +65.40% | 643B | |
| -0.75% | +0.67% | +33.18% | +86.52% | 450B | |
| -1.35% | +1.86% | +29.96% | +26.28% | 336B | |
| -0.86% | +2.79% | +37.72% | +40.85% | 298B | |
| -0.71% | +0.72% | +28.85% | +48.27% | 288B | |
| -1.31% | -0.26% | -28.18% | -39.82% | 222B | |
| -0.03% | +1.84% | +23.90% | +68.30% | 199B | |
| -0.40% | +7.82% | +22.29% | +82.50% | 169B | |
| Average | -1.06% | +2.60% | +32.30% | +88.55% | 370.62B | |
| Weighted average by Cap. | -1.16% | +2.71% | +41.37% | +86.56% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.78B 96.33M 84.49M 78M 72.08M 137M 9.22B 139M 938M 364M 4.51B 362M 354M 15.67B | 5.63B 113M 99.52M 91.88M 84.9M 161M 10.86B 164M 1.1B 429M 5.32B 426M 417M 18.46B |
| Net income | 564M 11.37M 9.97M 9.21M 8.51M 16.13M 1.09B 16.45M 111M 43.01M 533M 42.7M 41.77M 1.85B | 815M 16.43M 14.41M 13.3M 12.29M 23.3M 1.57B 23.77M 160M 62.14M 770M 61.69M 60.34M 2.67B |
| Net Debt | 2.01B 40.53M 35.54M 32.82M 30.32M 57.48M 3.88B 58.63M 394M 153M 1.9B 152M 149M 6.59B | 1.72B 34.71M 30.44M 28.11M 25.97M 49.23M 3.32B 50.21M 338M 131M 1.63B 130M 127M 5.65B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-08 | EGP 4.980 | -2.16% | 4,732,470 |
| 26-07-07 | EGP 5.090 | -0.20% | 4,330,092 |
| 26-07-06 | EGP 5.100 | +1.80% | 10,451,561 |
| 26-07-05 | EGP 5.010 | 0.00% | 1,974,770 |
| 26-07-01 | EGP 5.010 | +1.21% | 1,852,658 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RMDA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
